---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-011517"
form_type: "8-K"
ticker: "MBIO"
cik: "0001680048"
company_name: "MUSTANG BIO, INC."
filed_at: "2025-02-11T23:59:59+00:00"
generated_at: "2026-05-26T23:25:07.163667+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Mustang Bio closes $8M public offering, regains Nasdaq minimum bid compliance

## Summary
- Priced $8M offering of 2.66M shares (or equivalents) and Series C-1/C-2 warrants at $3.01 per unit; closed Feb 10, 2025.
- Net proceeds ~$6.9M; warrants exercisable upon stockholder approval at $3.01/share.
- Received Nasdaq notice of compliance with Bid Price Rule (minimum bid $1.00) after 1-for-50 reverse stock split on Jan 15.
- Company believes it now meets Nasdaq equity rule ($2.5M minimum) following offering; awaiting formal determination.

## SEC filing metadata
- accession: 0001104659-25-011517
- form_type: 8-K
- ticker: MBIO
- cik: 0001680048
- company_name: MUSTANG BIO, INC.
- filed_at: 2025-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680048/000110465925011517/0001104659-25-011517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680048/000110465925011517/tm255743d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-011517
- JSON: https://secwatch.observer/filing/0001104659-25-011517.json
- Plain text: https://secwatch.observer/filing/0001104659-25-011517.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
